Dermapharm Holding SE buy Snowman
Summary
This prediction ended on 20.05.22 with a price of €49.80. Massive losses of -30.50% were the result for the BUY prediction by Snowman. Snowman has 50% into this predictionDermapharm Holding is a Munich-based pharmaceutical company that develops innovative drug formulations and medical devices. It is listed on the Frankfurt Stock Exchange and has a strong presence in Germany and Europe. The company's product portfolio includes preparations for both prescription and over-the-counter drugs, as well as medical devices used in dermatology and urology. Dermapharm Holding differentiates itself from competitors by focusing on niche markets and developing new products in-house through its research and development activities.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Dermapharm Holding SE | -5.106% | -5.106% | -12.435% | -60.831% |
iShares Core DAX® | 0.936% | 1.535% | 21.949% | 19.324% |
iShares Nasdaq 100 | 3.064% | 1.968% | 29.275% | 38.772% |
iShares Nikkei 225® | 1.898% | -0.295% | 14.740% | 1.986% |
iShares S&P 500 | 1.653% | 2.318% | 27.064% | 40.403% |
Comments by Snowman for this prediction
In the thread Dermapharm Holding SE diskutieren
In the thread Trading Dermapharm Holding SE